As the 340B program continues to face judicial obstacles, pharmacy leaders must develop strategies to navigate complex legal landscapes surrounding drug rebate modeling. Recent judicial initiatives and their potential impacts are at the top of mind for many organizations. In this session, participants will explore case studies, legal interpretations, and proactive approaches to minimizing risk while maintaining program integrity and financial performance.
Learning Objectives:
1. Identify recent judicial rulings and their implications for 340B rebate calculation methodologies.
2. Compare comprehensive risk assessment frameworks to identify potential legal vulnerabilities in rebate modeling practices.
3. Analyze peer feedback regarding 340B rebate modeling difficulties to determine areas for improvement.
4. Outline methods to mitigate potential future judicial challenges to you 340B program’s operation.
Provider & GPO Focused by Invitation Only